Neogen (NEOG) Shares Outstanding (Diluted Average) (2018 - 2022)
Neogen's quarterly Shares Outstanding (Diluted Average) came in at $161.7 million in Q4 2022, up 49.54% year-on-year from $108.1 million in Q4 2021, and up 49.91% quarter-over-quarter from $107.9 million in Q3 2022.
Neogen has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $161.7 million in Q4 2022.
- For the quarter ending Q4 2022, Shares Outstanding (Diluted Average) rose 49.54% year-over-year to $161.7 million; the trailing twelve-month figure through Nov 2022 stood at $161.7 million (up 49.54% YoY), and the FY2022 full-year result was $108.0 million, up 0.84% from the prior year.
- Shares Outstanding (Diluted Average) for Q4 2022 stood at $161.7 million, up from $107.9 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $161.7 million in Q4 2022, with the low at $52.1 million in Q2 2018.
- Average Shares Outstanding (Diluted Average) over 5 years is $96.9 million, with a median of $106.9 million recorded in 2020.
- Year-over-year, Shares Outstanding (Diluted Average) surged 102.44% in 2021 and declined 0.23% in 2022.
- Tracing NEOG's Shares Outstanding (Diluted Average) over 5 years: stood at $52.1 million in 2018, then grew by 1.39% to $52.9 million in 2019, then surged by 101.6% to $106.6 million in 2020, then rose by 1.43% to $108.1 million in 2021, then jumped by 49.54% to $161.7 million in 2022.
- The last three Shares Outstanding (Diluted Average) figures came in at $161.7 million (Q4 2022), $107.9 million (Q3 2022), and $108.0 million (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | Neogen | 1.94 Bn | 1.78 Bn | 99.00 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Nov 30, 2022 | 161.69 Mn |
| Aug 31, 2022 | 107.86 Mn |
| May 31, 2022 | 108.02 Mn |
| Feb 28, 2022 | 108.13 Mn |
| Nov 30, 2021 | 108.12 Mn |
| Aug 31, 2021 | 108.11 Mn |
| May 31, 2021 | 107.12 Mn |
| Feb 28, 2021 | 107.39 Mn |
| Nov 30, 2020 | 106.60 Mn |
| Aug 31, 2020 | 106.57 Mn |
| May 31, 2020 | 105.72 Mn |
| Feb 29, 2020 | 53.05 Mn |
| Nov 30, 2019 | 52.88 Mn |
| Aug 31, 2019 | 52.68 Mn |
| May 31, 2019 | 104.85 Mn |
| May 31, 2018 | 52.15 Mn |